An Exploratory Open-Label, Single Dose, Randomized, Three-Way Crossover Study In Healthy Subjects to Investigate the Food Effect and Oral Bioavailability of Tablet Formulations Relative to Suspension Formulation of JNJ-54416076

Trial Profile

An Exploratory Open-Label, Single Dose, Randomized, Three-Way Crossover Study In Healthy Subjects to Investigate the Food Effect and Oral Bioavailability of Tablet Formulations Relative to Suspension Formulation of JNJ-54416076

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 27 Dec 2017

At a glance

  • Drugs JNJ 54416076 (Primary)
  • Indications Unspecified
  • Focus Pharmacokinetics
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 18 Dec 2017 Planned End Date changed from 1 Feb 2017 to 17 Feb 2017.
    • 18 Dec 2017 Planned primary completion date changed from 1 Feb 2017 to 17 Feb 2017.
    • 18 Dec 2017 Planned initiation date changed from 1 Oct 2016 to 22 Nov 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top